These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 2192724)
1. Cellular and humoral mediators of sepsis syndrome. Stroud M; Swindell B; Bernard GR Crit Care Nurs Clin North Am; 1990 Jun; 2(2):151-60. PubMed ID: 2192724 [TBL] [Abstract][Full Text] [Related]
2. Pathophysiology of septic shock and implications for therapy. Barron RL Clin Pharm; 1993 Nov; 12(11):829-45. PubMed ID: 8161370 [TBL] [Abstract][Full Text] [Related]
3. [[Antithrombin III concentrates in the treatmetn of sepsis and septic shock: indictions, limits and future prospects] ]. Baudo F; de Cataldo F Minerva Anestesiol; 2000 Nov; 66(11 Suppl 1):3-23. PubMed ID: 11213542 [TBL] [Abstract][Full Text] [Related]
5. [Antithrombin: prospects in clinical practice. Sespsi: anticoagulant or anti-inflammatory agents?]. Imberti D Minerva Anestesiol; 2003 May; 69(5):371-5. PubMed ID: 12768169 [TBL] [Abstract][Full Text] [Related]
6. Mediators of septic shock: new approaches for interrupting the endogenous inflammatory cascade. Giroir BP Crit Care Med; 1993 May; 21(5):780-9. PubMed ID: 8482101 [TBL] [Abstract][Full Text] [Related]
7. Sepsis and its complications: the clinical problem. Bone RC Crit Care Med; 1994 Jul; 22(7):S8-11. PubMed ID: 8026190 [TBL] [Abstract][Full Text] [Related]
8. The rat in sepsis and endotoxic shock. Wise WC; Cook JA; Tempel GE; Reines HD; Halushka PV Prog Clin Biol Res; 1989; 299():243-52. PubMed ID: 2657793 [TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor: an updated review of its biology. Tracey KJ; Cerami A Crit Care Med; 1993 Oct; 21(10 Suppl):S415-22. PubMed ID: 8403979 [TBL] [Abstract][Full Text] [Related]
12. Current prospects for the treatment of clinical sepsis. Suffredini AF Crit Care Med; 1994 Jul; 22(7):S12-8. PubMed ID: 8026188 [TBL] [Abstract][Full Text] [Related]
13. [Infection and septic shock. Aggression and defense]. Opferkuch W Verh Dtsch Ges Inn Med; 1987; 93():330-6. PubMed ID: 3442110 [No Abstract] [Full Text] [Related]
14. Immune cellular interactions during sepsis and septic injury. Jacobs RF; Tabor DR Crit Care Clin; 1989 Jan; 5(1):9-26. PubMed ID: 2647228 [TBL] [Abstract][Full Text] [Related]
15. Optimum treatment of severe sepsis and septic shock: evidence in support of the recommendations. Balk RA Dis Mon; 2004 Apr; 50(4):168-213. PubMed ID: 15133467 [TBL] [Abstract][Full Text] [Related]
16. [Characteristics of amino acid metabolism in patients with severe sepsis and septic shock]. Leĭderman IN; Rudnov VA; Logvinenko NN; Kogan EO Anesteziol Reanimatol; 1997; (1):45-8. PubMed ID: 9173819 [TBL] [Abstract][Full Text] [Related]
17. Management of severe sepsis and septic shock: challenges and recommendations. Gullo A; Bianco N; Berlot G Crit Care Clin; 2006 Jul; 22(3):489-501, ix. PubMed ID: 16893735 [TBL] [Abstract][Full Text] [Related]
18. [The heart in infection and MODS (multiple organ dysfunction syndrome)]. Müller-Werdan U; Prondzinsky R; Witthaut R; Stache N; Heinroth K; Kuhn C; Schmidt H; Busch I; Werdan K Wien Klin Wochenschr; 1997; 109 Suppl 1():3-24. PubMed ID: 9173672 [TBL] [Abstract][Full Text] [Related]
19. Septic shock; current pathogenetic concepts from a clinical perspective. Tsiotou AG; Sakorafas GH; Anagnostopoulos G; Bramis J Med Sci Monit; 2005 Mar; 11(3):RA76-85. PubMed ID: 15735579 [TBL] [Abstract][Full Text] [Related]
20. Role of tumor necrosis factor in sepsis and acute lung injury. Simpson SQ; Casey LC Crit Care Clin; 1989 Jan; 5(1):27-47. PubMed ID: 2647225 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]